ACA
Atlas Capital Advisors’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26 | Hold |
18
| – | – | ﹤0.01% | 919 |
|
|
2025
Q1 | $24 | Hold |
18
| – | – | ﹤0.01% | 979 |
|
|
2024
Q4 | $54 | Hold |
18
| – | – | ﹤0.01% | 921 |
|
|
2024
Q3 | $89 | Hold |
18
| – | – | ﹤0.01% | 897 |
|
|
2024
Q2 | $105 | Hold |
18
| – | – | ﹤0.01% | 884 |
|
|
2024
Q1 | $142 | Sell |
18
-878
| -98% | -$6.93K | ﹤0.01% | 877 |
|
|
2023
Q4 | $5.22K | Hold |
896
| – | – | ﹤0.01% | 790 |
|
|
2023
Q3 | $2.29K | Hold |
896
| – | – | ﹤0.01% | 801 |
|
|
2023
Q2 | $2.24K | Hold |
896
| – | – | ﹤0.01% | 821 |
|
|
2023
Q1 | $1.88K | Hold |
896
| – | – | ﹤0.01% | 837 |
|
|
2022
Q4 | $1.39K | Hold |
896
| – | – | ﹤0.01% | 844 |
|
|
2022
Q3 | $2.73K | Hold |
896
| – | – | ﹤0.01% | 819 |
|
|
2022
Q2 | $2.82K | Buy |
+896
| New | +$2.82K | ﹤0.01% | 892 |
|